Replay available

Rockwell Medical, Inc. (RMTI) Q1 2026 Earnings Call

Rockwell Medical, Inc. (NASDAQ: RMTI) Q1 2026 earnings conference call, held 2026-05-07. Replay captured from the company's public earnings webcast.

Thu, May 7, 2026 at 8:00 AMendedReplay
Rockwell Medical, Inc. (RMTI) Q1 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Heather Hunter

Chief Operating Officer

Jesse Meary

Chief Financial Officer

Jeremy Perlman

Analyst, Maxim Group

Dr. Mark Strobeck

President and Chief Executive Officer

Replay transcript excerpt

Hello, everyone. Thank you for joining us and welcome to Rockwell Medical's first quarter 2026 results conference call and webcast. Please note this event is being recorded. At this time, I would like to turn the conference over to Heather Hunter, Chief Operating Officer at Rockwell Med. Heather, please go ahead. Good morning and thank you for joining us for this update on Rockwell Medical. Joining me on today's conference call are Dr. Mark Strobeck, Rockwell Medical's President and Chief Executive Officer, and Jesse Meary, Rockwell Medical's Chief Financial Officer. Before we begin, I would like to remind you that this conference call will contain forward-looking statements about Rockwell Medical within the meaning of the federal securities laws, including but not limited to the types of statements identified as forward-looking in our annual report on Form 10-K and our subsequent periodic reports filed with the FCC. These statements are subject to risks and uncertainties that could cause actual results to differ. Please note that these forward-looking statements reflect our opinions and expectations only as of today. Except as required by law, we specifically disclaim any obligation to update or revise these forward-looking statements in light of new information or future events. Factors that could cause actual results or outcomes to differ materially from those expressed in or implied by such forward-looking statements are discussed in greater detail in our periodic reports filed with the SEC. Rockwell Medical's quarterly report on Form 10-Q for the three months ended March 31, 2026, was filed prior to this call and provides a full analysis of our business strategy as well as the company's first quarter 2026 results. The reconciliation of non-GAAP measures we discu...

More from Rockwell Medical, Inc.